Comon allelic variants of cytochrome P4503A and their prevalence in different populations

被引:46
|
作者
Maradiegue, Ann
Edwards, Quannetta T.
机构
[1] George Mason Univ, Coll Nursing & Hlth Sci, Falls Church, VA 22046 USA
[2] Howard Univ, Coll Pharm Nursing & Allied Hlth, Washington, DC 20059 USA
关键词
ethnicity; race; ancestry; family history; genetics; health disparities;
D O I
10.1111/j.1745-7599.2006.00156.x
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Purpose: To discuss the importance of and the nurse practitioner's (NP's) role in the assessment of ethnicity/family of origin in conducting a multigenerational family history in primary care settings. Data sources: A review of the literature on past research results addressing racial and ethnic disparities and current articles from scientific journals exploring the relationship between race and genetics. Web sites were from the National Institutes of Health, the Human Genome Research Institute, the National Cancer Institute, and the Health and Human Services Minority Health and Disparities report. Conclusions:The family history has received renewed interest due to the sequencing of the human genome. A multigenerational family history is an important first step in screening for a multitude of disorders impacted by genetic susceptibility, shared environments, and common behaviors. Assessment of the patient's ethnicity/family of origin is an integral part of the multigenerational family history, particularly in the diagnosis of chronic diseases and the assessment of risks for genetic disorders. The multigenerational family history is important in diagnosis, predictive genetic testing, disease prevention, and health promotion. Challenges facing NPs and the utilization of a multigenerational family history in the current U.S. health system include (a) training clinicians on the correct assessment and utilization of a multigenerational family history, (b) assessment of the subtleties of ethnicity and identifying multiple ethnic groups within a family, (c) collection of the family history in a manner that is sensitive to the cultural beliefs of individuals, and (d) avoidance of stereotyping Implictions for practice: Significant advances in genetics and genetic testing requires that NPs be well versed in collecting and interpreting a multigenerational family history to include assessment of the patient/family's ethnicity/family of origin. The ability to effectively conduct and evaluate the individual's and family's health risk through a multigenerational family history will be important in diagnosis, health promotion, disease prevention, and the determination for genetic counseling referral and predictive testing when appropriate. Assessment of risk and prevention of disease is also important in reducing health disparities.
引用
收藏
页码:447 / 456
页数:10
相关论文
共 50 条
  • [1] Common allelic variants of cytochrome P4503A4 and their prevalence in different populations
    Lamba, JK
    Lin, YS
    Thummel, K
    Daly, A
    Watkins, PB
    Strom, S
    Zhang, J
    Schuetz, EG
    PHARMACOGENETICS, 2002, 12 (02): : 121 - 132
  • [2] METABOLIC INTERACTIONS BETWEEN CYTOCHROME P4503A SUBSTRATES
    IRSHAID, Y
    ADEDOYIN, A
    BRANCH, RA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (02) : 139 - 139
  • [3] Biotransformation of alprazolam by members of the human cytochrome P4503A subfamily
    Gorski, JC
    Jones, DR
    Hamman, MA
    Wrighton, SA
    Hall, SD
    XENOBIOTICA, 1999, 29 (09) : 931 - 944
  • [4] VARIABILITY IN ALFENTANIL PHARMACOKINETICS - THE ESSENTIAL ROLE OF CYTOCHROME P4503A
    KHARASCH, ED
    ANESTHESIOLOGY, 1994, 81 (3A) : A381 - A381
  • [5] PHARMACOLOGICAL PROBES OF CYTOCHROME P4503A ACTIVITY AND CYCLOSPORINE CONCENTRATIONS
    STEIN, CM
    KINIRONS, MT
    PINCUS, T
    WILKINSON, GR
    WOOD, AJJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 57 (02) : 192 - 192
  • [6] Induction of cytochrome P4503A by the antiglucocorticoid mifepristone and a novel hypocholesterolaemic drug
    Williams, JA
    Chenery, RJ
    Berkhout, TA
    Hawksworth, GM
    DRUG METABOLISM AND DISPOSITION, 1997, 25 (06) : 757 - 761
  • [7] Mechanism for the prevention of cholestasis involving cytochrome P4503A overexpression
    Paolini, M
    Pozzetti, L
    Piazza, F
    Guerra, MC
    Speroni, E
    Cantelli-Forti, G
    Roda, A
    JOURNAL OF INVESTIGATIVE MEDICINE, 2000, 48 (01) : 49 - 59
  • [8] Transport proteins and intestinal metabolism - P-glycoprotein and cytochrome P4503A
    Christians, U
    THERAPEUTIC DRUG MONITORING, 2004, 26 (02) : 104 - 106
  • [9] Nafcillin is a potent inducer of cytochrome P4503A activity in humans.
    Lang, CC
    Mustafa, AM
    Jamal, SK
    Mustafa, MR
    Mohamed, Z
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R458 - R458
  • [10] Nafcillin is a potent inhibitor of cytochrome P4503A activity in humans.
    Lang, CC
    Mustafa, AM
    Jamal, SK
    Mustafa, MR
    Wood, AJJ
    Mohamed, Z
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 151 - 151